Homology Medicines Inc
FIXX
Market Cap$51.44M
Close$
$-0.34
136.9% downside
Current Fair Value
136.9% downsideOvervalued by 136.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $51.44 Million |
|---|---|
| Enterprise Value | $-29,898,444.00 |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.95 |
| Beta | 0.3 |
| Outstanding Shares | 58,133,540 |
| Avg 30 Day Volume | 324,393 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.46 |
|---|---|
| PEG | 0.86 |
| Price to Sales | - |
| Price to Book Ratio | 0.93 |
| Enterprise Value to Revenue | -25.86 |
| Enterprise Value to EBIT | 0.32 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.04 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
ESG Score
No data
About Homology Medicines Inc
CEO: Arthur Tzianabos